After Hours
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility.
Stocks Info
RCUS belongs to the Healthcare sector of the NYSE while operating in the Biotechnology industry. The current market capitalization of Arcus Biosciences Inc is $1.32B. A total of 1.41 million shares were traded on the day, compared to an average of 832.65K shares.
In the most recent transaction, Azoy Alexander sold 1,579 shares of RCUS for 11.88 per share on Sep 05 ’25. After the transaction, the Chief Accounting Officer now owns 30,194 company shares. In a previous transaction on Sep 05 ’25, ALEXANDER AZOY bought 1,579 shares at 11.56 per share.
Among the insiders who bought shares, KANEKO YASUNORI acquired of 20,000 shares on Feb 27 ’25 at a per-share price of $10.06. This resulted in the Director holding 28,400 shares of RCUS after the transaction. In another insider transaction, ROSEN TERRY J bought 19,800 shares at $10.18 per share on Feb 27 ’25. Company shares held by the Chief Executive Officer now total 2,554,160.
While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. In terms of 52-week highs and lows, RCUS has a high of $18.98 and a low of $6.50.
Balance Sheet Annually/Quarterly
An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. RCUS’s latest balance sheet shows that the firm has $499.00M in Cash & Short Term Investments as of fiscal 2021. There were $116.89M in debt and $166.00M in liabilities at the time. Its Book Value Per Share was $5.16, while its Total Shareholder’s Equity was $842.00M.
Analysts Opinion
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for RCUS is Buy with a score of 4.57.
